Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20305 | 404 | 32.6 | 78% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LACOSAMIDE | Author keyword | 142 | 66% | 32% | 131 |
2 | ESLICARBAZEPINE ACETATE | Author keyword | 137 | 93% | 13% | 52 |
3 | PERAMPANEL | Author keyword | 60 | 75% | 11% | 43 |
4 | ESLICARBAZEPINE | Author keyword | 59 | 90% | 6% | 26 |
5 | BIA 2 093 | Author keyword | 26 | 100% | 3% | 11 |
6 | PARTIAL ONSET SEIZURES | Author keyword | 18 | 45% | 7% | 30 |
7 | CARISBAMATE | Author keyword | 9 | 50% | 3% | 13 |
8 | RWJ 333369 | Author keyword | 8 | 75% | 1% | 6 |
9 | EISAI MED SCI AFFAIRS | Address | 6 | 80% | 1% | 4 |
10 | EISAI NEUROSCI GEN MED PCU | Address | 6 | 100% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LACOSAMIDE | 142 | 66% | 32% | 131 | Search LACOSAMIDE | Search LACOSAMIDE |
2 | ESLICARBAZEPINE ACETATE | 137 | 93% | 13% | 52 | Search ESLICARBAZEPINE+ACETATE | Search ESLICARBAZEPINE+ACETATE |
3 | PERAMPANEL | 60 | 75% | 11% | 43 | Search PERAMPANEL | Search PERAMPANEL |
4 | ESLICARBAZEPINE | 59 | 90% | 6% | 26 | Search ESLICARBAZEPINE | Search ESLICARBAZEPINE |
5 | BIA 2 093 | 26 | 100% | 3% | 11 | Search BIA+2+093 | Search BIA+2+093 |
6 | PARTIAL ONSET SEIZURES | 18 | 45% | 7% | 30 | Search PARTIAL+ONSET+SEIZURES | Search PARTIAL+ONSET+SEIZURES |
7 | CARISBAMATE | 9 | 50% | 3% | 13 | Search CARISBAMATE | Search CARISBAMATE |
8 | RWJ 333369 | 8 | 75% | 1% | 6 | Search RWJ+333369 | Search RWJ+333369 |
9 | LICARBAZEPINE ENANTIOMERS | 3 | 100% | 1% | 3 | Search LICARBAZEPINE+ENANTIOMERS | Search LICARBAZEPINE+ENANTIOMERS |
10 | LICARBAZEPINE | 3 | 60% | 1% | 3 | Search LICARBAZEPINE | Search LICARBAZEPINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ORAL LACOSAMIDE | 131 | 90% | 14% | 56 |
2 | PARTIAL ONSET SEIZURES | 83 | 34% | 49% | 196 |
3 | ADJUNCTIVE PERAMPANEL | 81 | 83% | 11% | 45 |
4 | BIA 2 093 | 76 | 88% | 9% | 36 |
5 | INTRAVENOUS LACOSAMIDE | 40 | 72% | 8% | 31 |
6 | ADJUNCTIVE LACOSAMIDE | 30 | 84% | 4% | 16 |
7 | SPM 927 | 27 | 83% | 4% | 15 |
8 | R LICARBAZEPINE | 23 | 100% | 2% | 10 |
9 | ESLICARBAZEPINE ACETATE | 22 | 62% | 6% | 23 |
10 | ANTICONVULSANT LACOSAMIDE | 21 | 64% | 5% | 21 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist | 2015 | 5 | 18 | 61% |
Adverse effects and safety profile of perampanel: A review of pooled data | 2014 | 7 | 4 | 100% |
Lacosamide as a new treatment option in status epilepticus | 2013 | 27 | 35 | 63% |
Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist | 2013 | 23 | 11 | 64% |
Eslicarbazepine acetate: An update on efficacy and safety in epilepsy | 2014 | 6 | 47 | 68% |
Lacosamide for the treatment of epilepsy | 2014 | 4 | 48 | 73% |
Current understanding of the mechanism of action of the antiepileptic drug lacosamide | 2015 | 3 | 122 | 26% |
Pharmacokinetics and drug interactions of eslicarbazepine acetate | 2012 | 23 | 39 | 59% |
Perampanel: A Selective AMPA Antagonist for Treating Seizures | 2013 | 4 | 12 | 92% |
Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures | 2009 | 64 | 22 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EISAI MED SCI AFFAIRS | 6 | 80% | 1.0% | 4 |
2 | EISAI NEUROSCI GEN MED PCU | 6 | 100% | 1.0% | 4 |
3 | CLIN SA O CORAZON | 2 | 67% | 0.5% | 2 |
4 | PHARMACEUT NEUROL SURG | 2 | 43% | 0.7% | 3 |
5 | ESTUDOS NEUROL | 1 | 100% | 0.5% | 2 |
6 | MULTIDISCIPLINARY EPILEPSY UNIT | 1 | 50% | 0.5% | 2 |
7 | PORTELA CA SA | 1 | 100% | 0.5% | 2 |
8 | HLTH SCI SECT | 1 | 17% | 1.7% | 7 |
9 | LIFE SCI RD PK | 1 | 40% | 0.5% | 2 |
10 | CLIN NEUROSCI PHYSIOL | 1 | 17% | 1.2% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000267728 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE |
2 | 0.0000226367 | ANTICONVULSANT ACTIVITY//MES TEST//EPILEPSY BRANCH |
3 | 0.0000198636 | RUFINAMIDE//CLOBAZAM//LENNOX GASTAUT SYNDROME |
4 | 0.0000167499 | LEVETIRACETAM//SV2A//BRIVARACETAM |
5 | 0.0000131202 | FRIEDEL CRAFTS CYCLIALKYLATION//HETEROPOLYCYCLES//HETEROARYLALKANOLS |
6 | 0.0000121939 | COLLAPSIN RESPONSE MEDIATOR PROTEIN//CRMP2//CRMP 2 |
7 | 0.0000121572 | RETIGABINE//FLUPIRTINE//KCNQ |
8 | 0.0000114399 | REMACEMIDE//LOSIGAMONE//REMACEMIDE HYDROCHLORIDE |
9 | 0.0000101585 | STATUS EPILEPTICUS//NONCONVULSIVE STATUS EPILEPTICUS//REFRACTORY STATUS EPILEPTICUS |
10 | 0.0000083842 | FIRST SEIZURE//SEIZURE RELAPSE//FIRST EPILEPTIC SEIZURE |